AFP and hepatocellular carcinoma: Our study showed that preoperative GGT levels can be employed as another effective marker to replace AFP as a predictor of prognosis in AFP-negative HCC patients, helping stratify the AFP-negative HCC patients who are at high risk of death and early recurrence.